Alendronate
The serum concentration of Alendronic acid can be decreased when it is combined with Iron saccharate.
Alendronic acid
The serum concentration of Alendronic acid can be decreased when it is combined with Iron saccharate.
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aluminum
Aluminium can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Asenapine
Asenapine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefdinir
The serum concentration of Cefdinir can be decreased when it is combined with Iron saccharate.
Chlortetracycline
The serum concentration of Chlortetracycline can be decreased when it is combined with Iron saccharate.
Cimetidine
Cimetidine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cinoxacin
The serum concentration of Cinoxacin can be decreased when it is combined with Iron saccharate.
Ciprofloxacin
The serum concentration of Ciprofloxacin can be decreased when it is combined with Iron saccharate.
Clodronic Acid
The serum concentration of Clodronic Acid can be decreased when it is combined with Iron saccharate.
Clofezone
Rabeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Iron saccharate.
Demeclocycline
The serum concentration of Demeclocycline can be decreased when it is combined with Iron saccharate.
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dibasic potassium phosphate
Iron saccharate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dimercaprol
Dimercaprol may increase the nephrotoxic activities of Iron saccharate.
Dolutegravir
The serum concentration of Dolutegravir can be decreased when it is combined with Iron saccharate.
Doxepin
Doxepin can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline
The serum concentration of Doxycycline can be decreased when it is combined with Iron saccharate.
Doxycycline Anhydrous
The serum concentration of Doxycycline can be decreased when it is combined with Iron saccharate.
Eltrombopag
The serum concentration of Eltrombopag can be decreased when it is combined with Iron saccharate.
Enoxacin
The serum concentration of Enoxacin can be decreased when it is combined with Iron saccharate.
Epinastine
Epinastine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Esomeprazole
Esomeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etidronate
The serum concentration of Etidronic acid can be decreased when it is combined with Iron saccharate.
Etidronic Acid
The serum concentration of Etidronic acid can be decreased when it is combined with Iron saccharate.
Famotidine
Famotidine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fleroxacin
The serum concentration of Fleroxacin can be decreased when it is combined with Iron saccharate.
Flumequine
The serum concentration of Flumequine can be decreased when it is combined with Iron saccharate.
Gatifloxacin
The serum concentration of Gatifloxacin can be decreased when it is combined with Iron saccharate.
Gatifloxacin Anhydrous
The serum concentration of Gatifloxacin can be decreased when it is combined with Iron saccharate.
Gemifloxacin
The serum concentration of Gemifloxacin can be decreased when it is combined with Iron saccharate.
Gemifloxacin Mesylate
The serum concentration of Gemifloxacin can be decreased when it is combined with Iron saccharate.
Grepafloxacin
The serum concentration of Grepafloxacin can be decreased when it is combined with Iron saccharate.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ibandronate
The serum concentration of Ibandronate can be decreased when it is combined with Iron saccharate.
Ibandronic Acid
The serum concentration of Ibandronate can be decreased when it is combined with Iron saccharate.
Lansoprazole
Lansoprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levodopa
The serum concentration of Levodopa can be decreased when it is combined with Iron saccharate.
Levofloxacin
The serum concentration of Levofloxacin can be decreased when it is combined with Iron saccharate.
Levofloxacin Anhydrous
The serum concentration of Levofloxacin can be decreased when it is combined with Iron saccharate.
Levothyroxine
The serum concentration of Levothyroxine can be decreased when it is combined with Iron saccharate.
Lomefloxacin
The serum concentration of Lomefloxacin can be decreased when it is combined with Iron saccharate.
Magaldrate
Magaldrate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Medronate
The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Iron saccharate.
Methantheline
Methantheline can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methyldopa
The serum concentration of Methyldopa can be decreased when it is combined with Iron saccharate.
METHYLDOPA ANHYDROUS
The serum concentration of Methyldopa can be decreased when it is combined with Iron saccharate.
Minocycline
The serum concentration of Minocycline can be decreased when it is combined with Iron saccharate.
Moxifloxacin
The serum concentration of Moxifloxacin can be decreased when it is combined with Iron saccharate.
Nalidixic Acid
The serum concentration of Nalidixic Acid can be decreased when it is combined with Iron saccharate.
Nizatidine
Nizatidine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Norfloxacin
The serum concentration of Norfloxacin can be decreased when it is combined with Iron saccharate.
Ofloxacin
The serum concentration of Ofloxacin can be decreased when it is combined with Iron saccharate.
Olanzapine
Olanzapine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Omeprazole
Omeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxytetracycline
The serum concentration of Oxytetracycline can be decreased when it is combined with Iron saccharate.
Oxytetracycline Anhydrous
The serum concentration of Oxytetracycline can be decreased when it is combined with Iron saccharate.
Pamidronate
The serum concentration of Pamidronate can be decreased when it is combined with Iron saccharate.
Pamidronic Acid
The serum concentration of Pamidronate can be decreased when it is combined with Iron saccharate.
Pancreatin
Pancrelipase can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pancrelipase
Pancrelipase can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
PANCRELIPASE PROTEASE
Pancrelipase can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pantoprazole
Pantoprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pefloxacin
The serum concentration of Pefloxacin can be decreased when it is combined with Iron saccharate.
Penicillamine
Iron saccharate can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Promethazine
Promethazine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rabeprazole
Rabeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ranitidine
Ranitidine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Risedronate
The serum concentration of Risedronate can be decreased when it is combined with Iron saccharate.
Risedronic Acid
The serum concentration of Risedronate can be decreased when it is combined with Iron saccharate.
Rosoxacin
The serum concentration of Rosoxacin can be decreased when it is combined with Iron saccharate.
Roxatidine Acetate
Roxatidine acetate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium glycerophosphate
Iron saccharate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Iron saccharate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Iron saccharate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate, Monobasic
Iron saccharate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Iron saccharate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sparfloxacin
The serum concentration of Sparfloxacin can be decreased when it is combined with Iron saccharate.
Technetium Tc 99m Medronate
The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Iron saccharate.
Temafloxacin
The serum concentration of Temafloxacin can be decreased when it is combined with Iron saccharate.
Tetracycline
The serum concentration of Tetracycline can be decreased when it is combined with Iron saccharate.
Thioctic Acid
Iron saccharate can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tiludronate
The serum concentration of Tiludronic acid can be decreased when it is combined with Iron saccharate.
Tiludronic Acid
The serum concentration of Tiludronic acid can be decreased when it is combined with Iron saccharate.
Trientine
The serum concentration of Iron saccharate can be decreased when it is combined with Triethylenetetramine.
Tromethamine
Tromethamine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trovafloxacin
The serum concentration of Trovafloxacin can be decreased when it is combined with Iron saccharate.
Zoledronic Acid
The serum concentration of Zoledronic acid can be decreased when it is combined with Iron saccharate.
Zoledronic Acid Anhydrous
The serum concentration of Zoledronic acid can be decreased when it is combined with Iron saccharate.
